Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; methyldopa - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; methyldopa and what is the scope of hydrochlorothiazide; methyldopa freedom to operate?

Hydrochlorothiazide; methyldopa
is the generic ingredient in five branded drugs marketed by Parke Davis, Merck, Dava Pharms Inc, Par Pharm, Teva, Watson Labs, Sandoz, Purepac Pharm, Ivax Sub Teva Pharms, and Mylan, and is included in forty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; methyldopa. One supplier is listed for this compound.

Summary for Generic Name: hydrochlorothiazide; methyldopa

Drug Master File Entries: see list31
Suppliers / Packagers: see list1
Clinical Trials: see list84
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; methyldopa at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide; methyldopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
hydrochlorothiazide; methyldopa
TABLET;ORAL070614-001Feb 2, 1987DISCNNoNo► Subscribe► Subscribe
Watson Labs
hydrochlorothiazide; methyldopa
TABLET;ORAL071920-001Aug 29, 1988DISCNNoNo► Subscribe► Subscribe
hydrochlorothiazide; methyldopa
TABLET;ORAL070265-001Jan 23, 1986RXNoYes► Subscribe► Subscribe
Dava Pharms Inc
hydrochlorothiazide; methyldopa
TABLET;ORAL072507-001Jun 2, 1989DISCNNoNo► Subscribe► Subscribe
Parke Davis
hydrochlorothiazide; methyldopa
TABLET;ORAL071898-001Nov 23, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus